1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Dr. Smitten has received consultant fees (more than $10,000) from Bristol-Myers Squibb.
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Rheumatoid Arthritis
You have full text access to this OnlineOpen article
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom
Article first published online: 29 NOV 2007
DOI: 10.1002/art.23112
Copyright © 2007 by the American College of Rheumatology
Additional Information
How to Cite
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A. and Chan, K. A. (2007), The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis & Rheumatism, 57: 1431–1438. doi: 10.1002/art.23112
Publication History
- Issue published online: 29 NOV 2007
- Article first published online: 29 NOV 2007
- Manuscript Accepted: 4 JUN 2007
- Manuscript Received: 6 OCT 2006
Funded by
- Harvard Pharmacoepidemiology Program
- Bristol-Myers Squibb Company
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Etanercept : efficacy and safety for approved indications, Expert Opinion on Drug Safety, 2012, 11, 1, 121
- 2, , , , , , Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up, International Journal of Rheumatic Diseases, 2012, 15, 2Direct Link:
- 3, , , , Risk of Herpes zoster in patients with psoriasis treated with biologic drugs, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 6Direct Link:
- 4, , , The Epidemiology and Prevention of Herpes Zoster, Current Dermatology Reports, 2012, 1, 1, 39
- 5, , Anti-TNF therapy: Safety aspects of taking the risk, Autoimmunity Reviews, 2011, 10, 9, 563
- 6, , Co-morbidities in established rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 469
- 7, , , Infectious Complications Associated with Immunomodulating Biologic Agents, Hematology/Oncology Clinics of North America, 2011, 25, 1, 117
- 8, , Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders, Journal of Dermatological Treatment, 2011, 22, 2, 90
- 9, , , Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study, Infection, 2011, 39, 6, 537
- 10, , , The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses, Arthritis Research & Therapy, 2011, 13, 4, R139
- 11, , , , , , , , , , The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study, Arthritis Research & Therapy, 2011, 13, 5, R174
- 12, , , , , , , , , , , , , , , , , Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases, Autoimmunity Reviews, 2011, 10, 6, 341
- 13, , , , A case of rheumatoid arthritis presenting with postherpetic neuralgia and abdominal-wall pseudohernia, Rheumatology International, 2010, 32, 6, 1775
- 14, , , , , , , , Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study, Rheumatology, 2010, 49, 11, 2104
- 15, , , , , Infections induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review, Joint Bone Spine, 2010, 77, 3, 246
- 16, , , , , Infections induites par de faibles doses de corticoïdes dans la polyarthrite rhumatoïde : revue systématique de la littérature, Revue du Rhumatisme, 2010, 77, 5, 467
- 17, , , Infectious Complications Associated with Immunomodulating Biologic Agents, Infectious Disease Clinics of North America, 2010, 24, 2, 285
- 18, , , Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2010, 69, 10, 879
- 19, , , Secondary syphilis occurring under anti-TNFα therapy, Joint Bone Spine, 2010, 77, 4, 364
- 20, , Tumor necrosis factor blockade and the risk of viral infection, Nature Reviews Rheumatology, 2010, 6, 3, 165
- 21, , , Une syphilis secondaire apparue sous traitement anti-TNF, Revue du Rhumatisme, 2010, 77, 4, 402
- 22, , , , , , , , , , , , , British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009, British Journal of Dermatology, 2009, 161, 5Direct Link:
- 23, , , , , Methotrexate, rheumatoid arthritis and infection risk--what is the evidence?, Rheumatology, 2009, 48, 8, 867
- 24, , Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?, Nature Reviews Rheumatology, 2009, 5, 7, 361
- 25, , , , DMARDS and infections in rheumatoid arthritis, Autoimmunity Reviews, 2008, 8, 2, 139
- 26, , , , , , , , , , , , , , Tolérance des glucocorticoïdes dans la polyarthrite rhumatoïde : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts, Revue du Rhumatisme, 2008, 75, S20
- 27, Viral infection and reactivation in autoimmune disease, Arthritis & Rheumatism, 2008, 58, 10Direct Link:
- 28, , , Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis), The Cochrane Library,Direct Link:
- 29Specific Therapeutic Agents,Direct Link: